Cargando…
Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)()
The 2019 Coronavirus disease (COVID-19) vaccine is a major weapon in the fight against the severe acute respiratory syndrome brought about by coronavirus 2 (SARS-CoV-2). The vaccine significantly reduces the risk and severity of infection by SARS-CoV-2. Patients with systemic lupus erythematosus (SL...
Autores principales: | Anuforo, Anderson, Sandhu, Michael, Yu, Jianghong, Perl, Andras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906889/ http://dx.doi.org/10.1016/j.clicom.2022.03.002 |
Ejemplares similares
-
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010) -
Malignancy in Systemic Lupus Erythematosus (SLE) Patients
por: Cader, Rizna Abdul, et al.
Publicado: (2018) -
New-Onset Systemic Lupus Erythematosus after mRNA SARS-CoV-2 Vaccination
por: Báez-Negrón, Laisha, et al.
Publicado: (2022) -
Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination
por: Rimmer, Sarah, et al.
Publicado: (2023) -
Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)